Regional chemotherapeutic techniques for liver tumors: Current knowledge and future directions

Surgical Clinics of North America

Volumn 84, Issue 2, 2004, Pages 607-625

  Elias, Dominique ^a   De Baere, Thierry ^a   Sideris, Lucas ^a   Ducreux, Michel ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; FLOXURIDINE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; MITOXANTRONE; OXALIPLATIN; PIRARUBICIN;

BLOOD TOXICITY; BOLUS INJECTION; CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL TRIAL; DOSE RESPONSE; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; GASTROINTESTINAL TOXICITY; HUMAN; HYPERBILIRUBINEMIA; INFUSION; INFUSION PUMP; LIVER FUNCTION TEST; LIVER METASTASIS; LIVER PERFUSION; LIVER TOXICITY; LIVER TUMOR; MEDICAL INFORMATION; PRIORITY JOURNAL; REVIEW; SCLEROSING CHOLANGITIS; SIDE EFFECT; SURGICAL TECHNIQUE;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOXURIDINE; HEPATIC ARTERY; HUMANS; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; ORGANOPLATINUM COMPOUNDS;

EID: 1642389863     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(03)00225-1     Document Type: Review

References (70)

1. Ragnhammar P., Hafstrom L., Nygren P., Glimelius B. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncol. 40:2001;282-308.
2. de Gramont A., Figer A., Seymour M., Homerin M., Hmissi A., Cassidi J., et al. Leucovorin and 5-FU with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 18:2000;2938-2947.
3. Saltz L.B., Cox J.V., Blanke C., Rosen L.S., Fehrenbacher L., Moore M.J., et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med. 343:2000;905-914.
4. Ackerman N.B. The blood supply of experimental liver metastases IV. Changes in vascularity with increasing tumor growth. Surgery. 75:(4):1974;589-596.
5. Giacchetti S., Itzhaki M., Gruia G., Adam R., Zidani R., Kunstlinger F., et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol. 10:1999;663-669.
6. Daly J.M., Kemeny M., Oderman P., Botet J. Long term hepatic arterial infusion chemotherapy. Arch Surg. 119:1984;936-941.
7. Elias D., Lasser P., Rougier P. A simplified surgical technical procedure for intra-arterial chemotherapy in secondary liver cancer. Experience in 50 patients. EJSO. 13:1987;441-448.
8. Elias D., Lasser P. Technique simplifiée d'implantation d'un catheter en cas d'artère hépatique droite unique. [Simplified techniques to insert an arterial catheter in case of right hepatic artery.] (In French). J Chir (Paris). 125:1988;54.
9. Elias D., Ducreux M., Rougier P., Commandella M., Deraco M., Ramirez L., et al. Intra-arterial hepatic chemotherapy. Analysis of 200 cases. Gastroentrol Clin Biol. 18:1994;975-982.
10. Franklin M., Gonzales J. Laparoscopic placement of hepatic artery catheter for regional chemotherapy infusion. Surg Laparosc Endosc Percutan Tech. 12:2002;398-407.
11. Habbe T.G., McCowan T.C., Goertzen T.C., Leveen R.F., Culp W.C., Tempero M.A., et al. Complications and technical limitations of hepatic arterial infusion catheter placement for chemotherapy. J Vasc Interv Radiol. 9:(2):1998;233-239.
12. Herrmann K.A., Waggershauser T., Sittek H., Reiser M.F. Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems. Radiology. 215:(1):2000;294-299.
13. Tanaka T., Arai Y., Inaba Y., Matsueda K., Aramaki T., Takeuchi Y., et al. Radiologic Placement of side-hole catheter with tip fixation for hepatic arterial infusion chemotherapy. J Vasc Interv Radiol. 14:(1):2003;63-68.
14. Zanon C., Grosso M., Clara R., Alabiso O., Chiappino I., Miraglia S., et al. Combined regional and systemic chemotherapy by a mini-invasive approach for the treatment of colorectal liver metastases. Am J Clin Oncol. 24:(4):2001;354-359.
15. Castaing D., Azoulay D., Fecteau A., Bismuth H. Implantable hepatic arterial infusion device: placement without laparotomy, via an intercostal artery. J Am Coll Surg. 187:1998;565-568.
16. Kemeny N., Daly J., Reichman B., Geller N., Botet J., Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med. 107:(4):1987;459-465.
17. Allen Mersh T.G., Earlam S., Fordy C., Abrams K., Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet. 344:(8932):1994;1255-1260.
18. Chang A.E., Schneider P.D., Sugarbaker P.H., Simpson C., Culnane M., Steinberg S.M. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg. 206:(6):1987;685-693.
19. Hohn D.C., Stagg R.J., Friedman M.A., Hannigan J.F. Jr., Rayner A., Ignoffo R.J., et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol. 7:(11):1989;1646-1654.
20. Martin J.K. Jr., O'Connell M.J., Wieand H.S., Fitzgibbons R.J. Jr., Mailliard J.A., Rubin J., et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg. 125:(8):1990;1022-1027.
21. Rougier P., Laplanche A., Huguier M., Hay J.M., Ollivier J.M., Escat J., et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol. 10:(7):1992;1112-1118.
22. Kemeny M.M., Goldberg D., Beatty J.D., Blayney D., Browning S., Doroshow J., et al. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer. 57:1986;492-498.
23. Meta-Analysis Group in Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst. 88:1996;252-258.
24. Lorenz M., Muller H.H. Randomized multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intraveous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol. 18:2000;243-254.
25. Kerr D.J., McArdle C.S., Ledermann J., Taylor I., Sherlock D.J., Schlag P.M., et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomized trial. Lancet. 361:(9355):2003;368-373.
26. Lorenz M., Mueller H.H., Mattes E., Gassel H.J., Junginger T., Saeger H.D., et al. Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5- fluorouracil and folinic acid for liver metastases from colorectal carcinomas. Ann Oncol. 12:(3):2001;321-325.
27. Bertuccelli M., Falcone A., Campoccia S., Conti M., Brunetti I., Caramella D., et al. Intrahepatic chemotherapy with floxuridine, leucovorin and dexamethasone in continuous infusion and mitomycin-C bolus in unresectable hepatic metastases from colorectal cancer: a phase II study. Tumori. 85:(6):1999;473-477.
28. Link K.H., Sunelaitis E., Kornmann M., Schatz M., Gansauge F., Leder G., et al. Regional chemotherapy of nonresectable colorectal liver metastases with mitoxantrone, 5-fluorouracil, folinic acid, and mitomycin C may prolong survival. Cancer. 92:(11):2001;2746-2753.
29. Fallik D., Ychou M., Jacob J., Colin P., Seitz J.F., Baulieux J., et al. Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with non resectable liver metastases from colorectal cancer. Ann Oncol. 16:2003;856-863.
30. Piedbois P. Intravenous CPT-11/5-FU/LV and hepatic artery infusion of pirarubicin in non operable liver metastases from colorectal cancer. A study of the A.E.R.O. Group. Ann Oncol. 13:(Suppl 5):2002;80-81.
31. Paty P., Kemeny N., Tong W., Sullivan D., Fong Y., Jarnagin W. A phase I/II study of hepatic arterial infusion (HAI) of floxuridine (FUDR) and dexamethasone (DEX) with systemic irinotecan (CPT-11) for unresectable hepatic metastases from colorectal cancer. Proceedings of the Annual Meeting of the American Society of Clinical Oncology. 19:2001;260a.
32. Kemeny N., Sullivan D., Price C., Schwartz L., Jarnagin W., Fong Y. A Phase I study of hepatic arterial infusion (HAI) of floxuridine (FUDR) dexamethasone plus systemic (SYS) oxaliplatin and irinotecan or HAI plus oxaliplatin and fluorouracil and leucovorin for unresectable hepatic metastases of colorectal cancer. Proceedings of the Annual Meeting of the American Society of Clinical Oncology. 2:2002;140a.
33. Ducreux M., Ychou M., Laplanche A., Gamelin E., Lasser P., Husseini F., et al. Intra-arterial hepatic chemotherapy (IAHC) with oxaliplatin (O) combined to intravenous treatment with 5-FU + folinic acid (FA) in hepatic metastases of colorectal cancer (HMCC). Final results of a trial of the french federation of anticancer centers. Proceedings of the Thirty-Ninth Annual Meeting of the American Society of Clinical Oncology, May 2003, Chicago, IL. 22:2003;278. A1115.
34. Boige V., Lacombe S., de Baere T., Pocard M., Elias D., Lasser P., et al. Hepatic arterial infusion of oxaliplatin combined with intravenous 5-FU and folinic acid in non resectable liver metastasis of colorectal cancer: a promising option for failures to systemic chemotherapy. Proceedings of the Thirty-Ninth Annual Meeting of the American Society of Clinical Oncology, May 2003, Chicago, IL. 22:2003;292. A1170.
35. Morris D.L., Zhao J., Clingan P.R. Previous intravenous chemotherapy does not alter response rate or survival time of patients with hepatic metastases from colorectal cancer treated by hepatic artery chemotherapy. Aust N Z J Surg. 67:(11):1997;796-797.
36. Grosso M., Zanon C., Zanon E., Corsico M., Gazzera C., Mancini A., et al. The percutaneous placement of intra-arterial catheters with "reservoirs" for subcutaneous infusion. The technic and preliminary results. Radiol Med (Torino). 94:(3):1997;226-232.
37. Aldrighetti L., Arru M., Angeli E., Venturini M., Salvioni M., Ronzoni M., et al. Percutaneous vs. surgical placement of hepatic artery indwelling catheters for regional chemotherapy. Hepatogastroenterology. 49:(44):2002;513-517.
38. Tanaka T., Inaba Y., Arai Y., Matsueda K., Aramaki T., Dendo S. Case report: hepatic arterial occlusion following infusion catheter placement: recanalization using the Palmaz stent. Br J Radiol. 74:(881):2001;448-451.
39. Elias D., Lasser P., Rougier P., Ducreux M., Bognel C., Roche A. Frequency, technical aspects, results and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg. 180:1995;213-219.
40. Bognel C., Degott C., Rougier P., Lasser P., Elias D., Grandjouan S., et al. Etude anatomo-pathologique de la toxicité hépatique de la chimiothérapie intra-arterielle hépatique. Gastroenterol Clin Biol. 13:1989;125-131.
41. Curley S.A., Roh M.S., Chase J.L., Hohn D.C. Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal metastases. Am J Surg. 166:1993;743-748.
42. Nonami T., Takeuchi Y., Yasui M., Kurokawa T., Taniguch K., Harada A., et al. Regional adjuvant chemotherapy after partial hepatectomy for metastatic colorectal carcinoma. Semin Oncol. 24:(Suppl 6):1997;130-134.
43. Reisener K.P., Winkeltau W., Kasperk R., Cheg L., Schumpelick V. Adjuvante regionale arterielle apres chemotherapice nach resektion colorectaler lebermetastasem. [Adjuvant regional chemotherapy following resection of colorectal hepatic metastases.] (In French). Chirurg. 69:1998;741-746.
44. Lorenz M., Muller H., Schramm H., Gassel H.J., Rau H.G., Ridwelski K., et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-FU and leucovorin for liver metastases of colorectal cancer. Ann Surg. 228:1998;756-762.
45. Kemeny N., Huang Y., Cohen A.M., Shi W., Conti J.A., Brennan M.F., et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med. 341:1999;2039-2048.
46. Kemeny M.M., Adak S., Gray B., Macdonald J.S., Smith T., Lipsitz S., et al. Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy. An intergroup study. J Clin Oncol. 20:2002;1499-1505.
47. Portier G., Rougier P., Milan C., Elias D., Bouché O., Gillet M., et al. Adjuvant systemic chemotherapy using 5-Fu and folinic acid after resection of liver metastases from colorectalorigin. Results of an intergroup phase III study (FFCD-ACHBT-AURC). Proceed Am Soc Clin Oncol. 21:2002;A528.
48. Langer B., Bleiberg H., Labianca R., Shepherd L., Nitti D., Marsoni D., et al. Fluorouracil plus leucovorin versus observation after potentially curative resection of liver or lung metastases from colorectal cancer: results of the ENG (EORTC-NCIC-GIVIO) trial. Proceed Am Soc Clin Oncol. 21:2002;A592.
49. Lau W.Y., Leung T.W., Cho S.K., Chan M., Lau J., Chan A.T., et al. Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial. Lancet. 353:1999;797-801.
50. Partensky C., Sassolas G., Henry L., Paliard P., Maddern G.J. Intra-arterial Iodine 131-labelled lipiodol adjuvant therapy after curative liver resection for hepatocellular carcinoma. Arch Surg. 135:2000;1298-1300.
51. Izumi R., Shimizy K., Iyobe T., Ii T., Yagi M., Matsui O., et al. Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology. 20:1994;295-301.
52. Lai C.S., Lo C.M., Fan S.T., Liu C.L., Wong J. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma. A randomized controlled study. Arch Surg. 133:1998;183-188.
53. Okuno K., Yasutomi M., Kon M., Hatakeyama K., Muto T., Kitajima M., et al. Intrahepatic interleukin-2 with chemotherapy for unresectable liver metastases: a randomized multicenter trial. Hepatogastroenterology. 46:1999;1116-1121.
54. Lattanzi J.P., Coia L.R., Scher R.M., Engstrom P.F., Hoffman J.P., Eisenberg B.F., et al. A prospective phase I/II study of intra-arterial chemotherapy and escalating doses of radiation therapy for surgically unresectable carcinoma confined to the liver. GI Cancer. 2:1997;111-117.
55. Shankar A., Loizidou M., Burnstock G., Taylor I. Noradrenaline improves the tumour to normal blood flow ratio and drug delivery in a model of liver metastases. Br J Surg. 86:1999;453-457.
56. Te Velde E.A., Vogten J.M., Gebbink M.F., van Gorp J.M., Voest E.E., Borel Rinkes I.H. Enhanced antitumour efficacy by combining conventional chemotherapy with angiostatin or endostatin in a liver metastasis model. Br J Surg. 89:2002;1302-1309.
57. Mearadji A., Breeman W., Hofland L., van Koestveld P., Marquet R., Jeekel J., et al. Somatostatin receptor gene therapy combined with targeted therapy with radiolabeled octreotide. A new treatment for liver metastase. Ann Surg. 236:2002;722-729.
58. Taylor I., Machin D., Mullee M., Trotter G., Cooke T., West C. A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer. Br J Surg. 72:(5):1985;359-363.
59. Gray B.N., de Zwart J., Fisher R., Burns I., Hurley R., Isbister W., et al. The Australia and New Zealand trial of adjuvant chemotherapy in colon cancer. Salmon S.E. Adjuvant therapy of cancer. 1987;537-554 Grune & Stratton, New York.
60. Ryan J., Weiden P., Crowley J., Bloch K. Adjuvant portal vein infusion for colorectal cancer. A 3-arm randomised trial. Proc Am Soc Clin Oncol. 7:1988;95.
61. Wereldsma J.C., Bruggink E.D., Meijer W.S., Roukema J.A., van Putten W.L. Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/ heparin versus urokinase versus control. Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I). Cancer. 65:(3):1990;425-432.
62. Beart R.W. Jr., Moertel C.G., Wieand H.S., Leigh J.E., Windschitl H.E., Van Heerden J.A., et al. Adjuvant therapy for resectable colorectal carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and the North Central Cancer Treatment Group. Arch Surg. 125:(7):1990;897-901.
63. Wolmark N., Rockette H., Wickerham D.L., Fisher B., Redmond C., Fisher E.R., et al. Adjuvant therapy of Dukes A, B, and C adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of National Surgical Adjuvant Breast and Bowel Project Protocol C-02. J Clin Oncol. 8:1990;1466-1475.
64. Fielding L.P., Hittinger R., Grace R.H., Fry J.S. Randomized controlled trial of adjuvant chemotherapy by portal- vein perfusion after curative resection for colorectal adenocarcinoma. Lancet. 340:1992;502-506.
65. Swiss Group for Clinical Cancer Research (SAKK). Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Lancet. 345:(8946):1995;349-353.
66. Rougier P., Sahmoud T., Nitti D., Curran D., Doci R., De Waele B., et al. Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial. Lancet. 351:1998;1677-1681.
67. Laffer U., Maibach R., Metzger U., Stamm B., Weber W., Waltzer U., et al. Randomized trial of adjuvant perioperative chemotherapy in radically resected colorectal cancer (SAKK 40/87). Proceedings of the Annual Meeting of the American Society of Clinical Oncology. 17:1998;256a.
68. Wolmark N., Rockette H., Petrelli N., Jones J., Redmond C., Fisher B., et al. Long-term results of the efficacy of perioperative portal vein infusion of 5-FU for treatment of colon cancer: NSABP C-02. Proceedings of the Annual Meeting of the American Society of Clinical Oncology. 13:1994;194.
69. Liver Infusion Meta-analysis Group. Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. J Natl Cancer Inst. 89:(7):1997;497-505.
70. Focan C., Bury J., Beauduin M., Herman M.L., Vindevoghel A., Brohee D., et al. Adjuvant intraportal chemotherapy for Dukes B2 and C colorectal cancer also receiving systemic treatment: results of a multicenter randomized trial. Groupe Regional d'Etude du Cancer Colo-Rectal (Belgium). Anticancer Drug Des. 11:(7):2000;549-554.